This article summarized the latest R&D progress of Idoxuridine, the Mechanism of Action for Idoxuridine, and the drug target R&D trends for Idoxuridine.
This article summarized the latest R&D progress of Flurandrenolide, the Mechanism of Action for Flurandrenolide, and the drug target R&D trends for Flurandrenolide.
This article summarized the latest R&D progress of Succinylcholine Chloride, the Mechanism of Action for Succinylcholine Chloride, and the drug target R&D trends for Succinylcholine Chloride.
This article summarized the latest R&D progress of Savolitinib, the Mechanism of Action for Savolitinib, and the drug target R&D trends for Savolitinib.
This article summarized the latest R&D progress of Pralsetinib, the Mechanism of Action for Pralsetinib, and the drug target R&D trends for Pralsetinib.
This article summarized the latest R&D progress of Pralatrexate, the Mechanism of Action for Pralatrexate, and the drug target R&D trends for Pralatrexate.
This article summarized the latest R&D progress of Pemafibrate, the Mechanism of Action for Pemafibrate, and the drug target R&D trends for Pemafibrate.
Luliconazole is a small molecule drug that falls under the therapeutic areas of Infectious Diseases and Skin and Musculoskeletal Diseases. It primarily targets fungal CYP51A1.